Cargando…
Approaches to the Management of Agents Used for the Treatment of Multiple Sclerosis: Consensus Statements from a Panel of U.S. Managed Care Pharmacists and Physicians
BACKGROUND: Multiple sclerosis (MS) is a chronic, disabling, and costly disease with several treatment options available; however, there is variability in evidence-based clinical guidelines. Therefore, payers are at a disadvantage when making management decisions without the benefit of definitive gu...
Autores principales: | Miller, Ross M., Happe, Laura E., Meyer, Kellie L., Spear, Rachel J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437556/ https://www.ncbi.nlm.nih.gov/pubmed/22235955 http://dx.doi.org/10.18553/jmcp.2012.18.1.54 |
Ejemplares similares
-
Consensus Statements from a Panel of U.S. Managed Care Pharmacists and Physicians for Management of Multiple Sclerosis Agents
por: Kern, Ralph, et al.
Publicado: (2012) -
Consensus Statements from a Panel of U.S. Managed Care Pharmacists and Physicians for Management of Multiple Sclerosis Agents (2)
por: Phillips, J. Theodore
Publicado: (2012) -
Evaluation of Personal Digital Assistant Drug Information Databases for the Managed Care Pharmacist
por: Lowry, Colleen M., et al.
Publicado: (2003) -
Assessment of Clinical Pharmacist Management of Lipid-Lowering Therapy in a Primary Care Setting
por: Till, Traywick L, et al.
Publicado: (2003) -
Lipid Levels and Use of Lipid-Lowering Drugs for Patients in Pharmacist-Managed Lipid Clinics Versus Usual Care in 2 VA Medical Centers
por: Mazzolini, Timothy A., et al.
Publicado: (2005)